InsidersTradesSigma
Track the 海正药业 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 海正药业 has recorded 1 public disclosures. Market capitalisation: €13.7bn. The latest transaction was reported on 2 August 2022 (Purchase). Among the most active insiders: 喻舜兵. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
€1,658
1 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,764 of 29,062 companies
63.1
score / 100
Value70
Quality56
FCF yld12%
Earn yld4.0%
EV/EBITDA8.8x
ROE7.9%
Gross mgn45%
Net mgn5.1%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 August 2022
About 海正药业
海正药业 is a Chinese company in the pharmaceutical sector, focused on the research, development, and manufacturing of medications. It is listed on the Shanghai Stock Exchange.